SCHEMBL49736

SCHEMBL49736

OCCC1CNCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20878692 1.00
SCHEMBL27919907 1.00
Fluoride SCHEMBL4618894 1.00 SLC6A2 (0.38)
Hydrochloric Acid SCHEMBL9696636 0.98 SLC6A2 (0.38)
Bromide SCHEMBL11805148 0.98 SLC6A2 (0.38)
Sulfuric Acid SCHEMBL17673108 0.91 SLC6A2 (0.37)
SCHEMBL1260402 0.88 SLC6A2 (0.37)
SCHEMBL17131027 0.88 SLC6A2 (0.37)
SCHEMBL18531916 0.88 SLC6A2 (0.37)
SCHEMBL1746181 0.86 SLC6A2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2105 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4204609-B1 COMPOSITIONS AND METHODS FOR THE ELECTRODEPOSITION OF NANOTWINNED COPPER MACDERMID ENTHONE INC (US) 2026-05-27 EP claimed
US-12616699-B2 Ophthalmic formulations of methotrexate ALDEYRA THERAPEUTICS, INC. (US) 2026-05-05 US claimed
US-20260068874-A1 AGROCHEMICAL FORMULATION SOLVENTS ROSENS INC (US) 2026-03-12 US claimed
CN-120051593-A Compositions and methods for nano twinned copper formation 麦克德米德乐思公司 2025-05-27 CN claimed
WO-2025082316-A1 OPHTHALMIC FORMATION, AND PREPARATION METHOD THEREFOR AND USE THEREOF 苏州必扬医药科技有限公司 2025-04-24 WO claimed
EP-3861150-B1 METHOD OF CONTROLLING CORROSION IN AN AQUEOUS HEAT TRANSFER SYSTEM BY THE PARTIAL DECOMPOSITION OF THE MORPHOLINE GENERATING AGENT IN THE AQUEOUS HEAT TRANSFER SYSTEM TO FORM MORPHOLINE INSITU HUNTSMAN PETROCHEMICAL LLC (US) 2025-04-02 EP claimed
CN-116554249-B Antiviral compounds and uses thereof 北京恩泰伟医药科技有限公司 2025-03-18 CN claimed
EP-4474369-A1 UREASE INHIBITOR COMPOSITION AND THE UREA FERTILIZER COMPOSITION COMPRISING THE SAME SPECIALTY OPERATIONS FRANCE (FR) 2024-12-11 EP claimed
CN-119019999-A Electric automobile cooling liquid and preparation method thereof 上海德联化工有限公司 2024-11-26 CN claimed
CN-118085973-A Post-chemical mechanical polishing formulations and methods of use thereof 恩特格里斯公司 2024-05-28 CN claimed
CN-1100076-C Curable composition SMITH & NEPHEW (GB) 2003-01-29 CN claimed
EP-1226126-A1 PYRIMIDINE DERIVATIVES AstraZeneca AB (SE) 2002-07-31 EP claimed
WO-2001027089-A1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2001-04-19 WO claimed
CN-1202182-A Curable compositions SMITH & NEPHEW (GB) 1998-12-16 CN claimed
EP-0809103-A2 Stable denaturants for use in electrophoretic techniques and methods of using the same FMC CORPORATION (US) 1997-11-26 EP claimed
EP-0362787-A2 Modified amino curing agents for epoxy resins HENKEL RESEARCH CORPORATION (US) 1990-04-11 EP claimed
EP-0060974-A2 Amino and amidodiorgano tin carboxylates AIR PRODUCTS AND CHEMICALS, INC. (US) 1982-09-29 EP claimed
US-4339369-A HYDROXY CONTAINING TERT-AMINE CELANESE CORPORATION (US) 1982-07-13 US claimed
US-4219626-A Accelerators for radical polymerization reactions with initiators free from peroxide groups BAYER AKTIENGESELLSCHAFT (DE) 1980-08-26 US claimed
US-4062956-A Substituted 2-(2-hydroxyethyl)tetrahydro-1,4 oxazines and quaternary salts thereof useful for treating spasmodic syndromes CENTRE EUROPEEN DE RECHERCHES MAUVERNAY (FR) 1977-12-13 US claimed